Eating mushrooms may reduce the risk of cognitive decline

by National University of SingaporeA six-year study, led by Assistant Professor Lei Feng (left) from the National University of Singapore, found that seniors who ate more than 300 grams of cooked

Updated on: May 06,2024

Eating mushrooms may reduce the risk of cognitive decline

by National University of SingaporeA six-year study, led by Assistant Professor Lei Feng (left) from the National University of Singapore, found that seniors who ate more than 300 grams of cooked

Updated on:May 06,2024

Understanding genetic risk could save sight and predict multiple sclerosis earlier in young people

byUniversity of ExeterCredit: CC0 Public DomainYoung people could be spared from going blind by a new genetic risk tool that could also help diagnose multiple sclerosis (MS) earlier, to start ef

Updated on: April 22,2024

Understanding genetic risk could save sight and predict multiple sclerosis earlier in young people

byUniversity of ExeterCredit: CC0 Public DomainYoung people could be spared from going blind by a new genetic risk tool that could also help diagnose multiple sclerosis (MS) earlier, to start ef

Updated on:April 22,2024

What an animated taco reveals about curiosity and patience

byDuke UniversityCredit: Pixabay/CC0 Public DomainCuriosity paradoxically increases people's patience for an answer, while simultaneously making them more eager to hear it, finds a new study

Updated on: January 12,2024

What an animated taco reveals about curiosity and patience

byDuke UniversityCredit: Pixabay/CC0 Public DomainCuriosity paradoxically increases people's patience for an answer, while simultaneously making them more eager to hear it, finds a new study

Updated on:January 12,2024

Alzheimer's gene-mapping project proposed in New York state

A proposed project to map the genes of 1 million people in New York living with or at risk for Alzheimer disease was announced Friday by Gov. Andrew Cuomo.He said the five years of data collected by t

Updated on: April 20,2024

Alzheimer's gene-mapping project proposed in New York state

A proposed project to map the genes of 1 million people in New York living with or at risk for Alzheimer disease was announced Friday by Gov. Andrew Cuomo.He said the five years of data collected by t

Updated on:April 20,2024

Amyloid is a less accurate marker for measuring severity, progression of Alzheimer's

by Perelman School of Medicine at the University of PennsylvaniaPET imaging using the radiotracers FDG and florbetapir to quantify cognitive decline in patients with Alzheimer’s disease (AD), mil

Updated on: May 22,2024

Amyloid is a less accurate marker for measuring severity, progression of Alzheimer's

by Perelman School of Medicine at the University of PennsylvaniaPET imaging using the radiotracers FDG and florbetapir to quantify cognitive decline in patients with Alzheimer’s disease (AD), mil

Updated on:May 22,2024

Dementia study reveals how toxic proteins spread through brain

by University of EdinburghGraphical Abstract. Credit:Neuron(2023). DOI: 10.1016/j.neuron.2023.04.020Fresh insights into the spread of damaging proteins that build up in the brains of

Updated on: February 03,2024

Dementia study reveals how toxic proteins spread through brain

by University of EdinburghGraphical Abstract. Credit:Neuron(2023). DOI: 10.1016/j.neuron.2023.04.020Fresh insights into the spread of damaging proteins that build up in the brains of

Updated on:February 03,2024

Extra-large synapses could be a cause of schizophrenia

by RIKENExtra-strong synapses could play an important role in psychiatric disorders such as schizophrenia, a study by RIKEN researchers finds. Credit: Equinox Graphics/Science Photo LibrarySchizo

Updated on: February 03,2024

Extra-large synapses could be a cause of schizophrenia

by RIKENExtra-strong synapses could play an important role in psychiatric disorders such as schizophrenia, a study by RIKEN researchers finds. Credit: Equinox Graphics/Science Photo LibrarySchizo

Updated on:February 03,2024

Overlooked proteins may be key to better diagnosis of Alzheimer's

by University of California, San FranciscoCredit: Pixabay/CC0 Public DomainIn a new study of Alzheimer's disease, researchers at UC San Francisco have discovered that a relatively unstudied f

Updated on: April 29,2024

Overlooked proteins may be key to better diagnosis of Alzheimer's

by University of California, San FranciscoCredit: Pixabay/CC0 Public DomainIn a new study of Alzheimer's disease, researchers at UC San Francisco have discovered that a relatively unstudied f

Updated on:April 29,2024

Hidden financial dimensions affect people with cognitive decline and their care partners, report says

by The Gerontological Society of AmericaCredit: CC0 Public DomainIn planning for older adulthood, many people both fear and consistently underestimate the risk of Alzheimer's disease and related d

Updated on: April 29,2024

Hidden financial dimensions affect people with cognitive decline and their care partners, report says

by The Gerontological Society of AmericaCredit: CC0 Public DomainIn planning for older adulthood, many people both fear and consistently underestimate the risk of Alzheimer's disease and related d

Updated on:April 29,2024

Computer simulations explore how Alzheimer's disease starts

by Rice UniversityA team of Rice University researchers built computer simulations of amyloid beta proteins to see what their energy landscapes reveal about the formation of plaques in patients w

Updated on: June 18,2024

Computer simulations explore how Alzheimer's disease starts

by Rice UniversityA team of Rice University researchers built computer simulations of amyloid beta proteins to see what their energy landscapes reveal about the formation of plaques in patients w

Updated on:June 18,2024

Alzheimer's drug gets FDA panel's backing, setting the stage for broader use

by Matthew PerroneThis Dec. 21, 2022, image provided by Eisai in January 2023 shows vials and packaging for their medication Leqembi. On Friday, June 9, 2023, health advisers backed the full approval

Updated on: April 16,2024

Alzheimer's drug gets FDA panel's backing, setting the stage for broader use

by Matthew PerroneThis Dec. 21, 2022, image provided by Eisai in January 2023 shows vials and packaging for their medication Leqembi. On Friday, June 9, 2023, health advisers backed the full approval

Updated on:April 16,2024

Alzheimer's disease: Sex affects tau accumulation in the brain

by Society of Nuclear Medicine and Molecular ImagingSex Modulates the ApoE ε4 Effect on 18F-AV-1451 Tau PET. Credit: Paranjpe M, Liu M, Paranjpe I, et al.The strongest genetic risk factor for Alzheime

Updated on: April 10,2024

Alzheimer's disease: Sex affects tau accumulation in the brain

by Society of Nuclear Medicine and Molecular ImagingSex Modulates the ApoE ε4 Effect on 18F-AV-1451 Tau PET. Credit: Paranjpe M, Liu M, Paranjpe I, et al.The strongest genetic risk factor for Alzheime

Updated on:April 10,2024